Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 16251 - 16275 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Custirsen	Investigational	PLEKHM2	23207	upregulated	CC-8490 results in increased expression of PLEKHM2 mRNA	1p36.21	A3616
Custirsen	Investigational	RND3	390	upregulated	CC-8490 results in increased expression of RND3 mRNA	2q23.3	A3616
Custirsen	Investigational	SLC3A2	6520	upregulated	CC-8490 results in increased expression of SLC3A2 mRNA	11q12.3	A3616
Custirsen	Investigational	SOD2	6648	upregulated	CC-8490 results in increased expression of SOD2 mRNA	6q25.3	A3616
Custirsen	Investigational	SPHK1	8877	upregulated	CC-8490 results in increased expression of SPHK1 mRNA	17q25.2	A3616
Custirsen	Investigational	STC2	8614	downregulated	CC-8490 results in decreased expression of STC2 mRNA	5q35.2	A3616
Custirsen	Investigational	TOP1	7150	upregulated	CC-8490 results in increased expression of TOP1 mRNA	20q12	A3616
Custirsen	Investigational	WTAP	9589	upregulated	CC-8490 results in increased expression of WTAP mRNA	6q25.3	A3616
Cefaclor	Approved Investigational	CYP3A4	1576	upregulated	Cefaclor results in increased expression of CYP3A4 mRNA	7q22.1	A15703
Cefadroxil	Approved Investigational Vet Approved Withdrawn	CYP3A4	1576	upregulated	Cefadroxil results in increased expression of CYP3A4 mRNA	7q22.1	A15703
Celecoxib	Approved Investigational	ABCB1	5243	upregulated	Celecoxib results in increased expression of ABCB1 mRNA	7q21.12	A21561
Celecoxib	Approved Investigational	ABCC1	4363	downregulated	Celecoxib results in decreased expression of ABCC1 mRNA	16p13.11	A21562
Celecoxib	Approved Investigational	ABCC1	4363	upregulated	Celecoxib results in increased expression of ABCC1 mRNA	16p13.11	A21561
Celecoxib	Approved Investigational	ABCC4	10257	upregulated	Celecoxib results in increased expression of ABCC4 mRNA	13q32.1	A21563
Celecoxib	Approved Investigational	ABCC5	10057	upregulated	Celecoxib results in increased expression of ABCC5 mRNA	3q27.1	A21563
Celecoxib	Approved Investigational	ABCG2	9429	downregulated	Celecoxib results in decreased expression of ABCG2 mRNA	4q22.1	A21562
Celecoxib	Approved Investigational	BAK1	578	upregulated	Celecoxib results in increased expression of BAK1 mRNA	6p21.31	A21564
Celecoxib	Approved Investigational	BAX	581	downregulated	Celecoxib results in decreased expression of BAX mRNA	19q13.33	A20938
Celecoxib	Approved Investigational	BCL2	596	upregulated	Celecoxib results in increased expression of BCL2 mRNA	18q21.33	A20938
Celecoxib	Approved Investigational	BCL2L1	598	upregulated	Celecoxib results in increased expression of BCL2L1 mRNA	20q11.21	A20938
Celecoxib	Approved Investigational	BIRC5	332	downregulated	Celecoxib results in decreased expression of BIRC5 mRNA	17q25.3	A21565 A21566
Celecoxib	Approved Investigational	BIRC5	332	upregulated	Celecoxib results in increased expression of BIRC5 mRNA	17q25.3	A20938
Celecoxib	Approved Investigational	CCND1	595	downregulated	Celecoxib results in decreased expression of CCND1 mRNA	11q13.3	A21565
Celecoxib	Approved Investigational	CCND2	894	downregulated	Celecoxib results in decreased expression of CCND2 mRNA	12p13.32	A21564
Celecoxib	Approved Investigational	CDKN1A	1026	upregulated	Celecoxib results in increased expression of CDKN1A mRNA	6p21.2	A21567 A21568

Displaying entries 16251 - 16275 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability